Millennium Management’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $291K | Sell |
64,631
-265,836
| -80% | -$1.2M | ﹤0.01% | 3585 |
|
|
2025
Q1 | $1.53M | Buy |
330,467
+284,097
| +613% | +$1.32M | ﹤0.01% | 2764 |
|
|
2024
Q4 | $322K | Buy |
46,370
+15,749
| +51% | +$109K | ﹤0.01% | 3479 |
|
|
2024
Q3 | $162K | Buy |
30,621
+9,693
| +46% | +$51.4K | ﹤0.01% | 3778 |
|
|
2024
Q2 | $78.3K | Sell |
20,928
-129,097
| -86% | -$483K | ﹤0.01% | 3737 |
|
|
2024
Q1 | $1.06M | Buy |
150,025
+82,746
| +123% | +$583K | ﹤0.01% | 2926 |
|
|
2023
Q4 | $380K | Buy |
+67,279
| New | +$380K | ﹤0.01% | 3300 |
|
|
2023
Q2 | – | Sell |
-117,094
| Closed | -$912K | – | 4403 |
|
|
2023
Q1 | $912K | Sell |
117,094
-276,056
| -70% | -$2.15M | ﹤0.01% | 3108 |
|
|
2022
Q4 | $2.99M | Buy |
393,150
+367,221
| +1,416% | +$2.79M | ﹤0.01% | 2435 |
|
|
2022
Q3 | $212K | Buy |
25,929
+8,526
| +49% | +$69.7K | ﹤0.01% | 4405 |
|
|
2022
Q2 | $168K | Buy |
+17,403
| New | +$168K | ﹤0.01% | 4523 |
|
|
2021
Q4 | – | Sell |
-175,445
| Closed | -$3.91M | – | 5344 |
|
|
2021
Q3 | $3.91M | Sell |
175,445
-59,657
| -25% | -$1.33M | ﹤0.01% | 2420 |
|
|
2021
Q2 | $5.34M | Buy |
+235,102
| New | +$5.34M | ﹤0.01% | 2068 |
|